Beeck Regine, Dols Annemarie, Schneider Felix, Seradj Dariah-Sohreh, Krause Julius, Schick Philipp, Weitschies Werner
Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, D-17489 Greifswald, Germany.
Pharmaceutics. 2022 May 13;14(5):1049. doi: 10.3390/pharmaceutics14051049.
In recent years, the colon has become a hot topic in biopharmaceutical research as several in vitro models of the human colon have been presented. A major focus is on the characterization of the microbiota and its capabilities. The aim of the present study was to further develop the MimiCol, preserving its properties and accelerating data acquisition. Emphasis was placed on the simplicity of its design and easy scalability. To prove the viability of the concept, degradation of sulfasalazine was investigated, and the bacterial composition during the experiment was assessed by 16S rRNA sequencing. The transfer of the experimental conditions to the new model was successful. Commercially available components were implemented in the setup. The model MimiCol represented the colon ascendens satisfactorily in its properties regarding volume, pH value, and redox potential. 16S rRNA sequencing led to further insights into the bacterial composition in the vessels. Degradation of sulfasalazine was in good agreement with in vivo data. The new model of the colon ascendens MimiCol enabled us to collect more reliable data, as three experiments were conducted simultaneously under the same conditions.
近年来,随着几种人类结肠体外模型的出现,结肠已成为生物制药研究中的一个热门话题。主要关注点在于微生物群的特征及其功能。本研究的目的是进一步开发MimiCol,保留其特性并加速数据采集。重点在于其设计的简单性和易于扩展性。为了证明该概念的可行性,研究了柳氮磺胺吡啶的降解情况,并通过16S rRNA测序评估了实验过程中的细菌组成。实验条件向新模型的转移是成功的。在设置中采用了市售组件。MimiCol模型在体积、pH值和氧化还原电位方面令人满意地代表了升结肠的特性。16S rRNA测序使我们对容器中的细菌组成有了进一步了解。柳氮磺胺吡啶的降解与体内数据高度一致。升结肠MimiCol新模型使我们能够收集更可靠的数据,因为在相同条件下同时进行了三个实验。